TRVI compared with SVRA: revenue, margins and what each company keeps, and the suppliers and customers both name

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

SVRASavara Inc

Mkt capRevenueRevenue

Compare

TRVITrevi Therapeutics, Inc.

SVRASavara Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TRVI: latest quarter not drawable. SVRA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TRVI 2

—Keenova Therapeuticsunlistedsupplier

—Par Healthunlistedsupplier

Shared 0

No shared counterparties.

Only SVRA 7

—FUJIFILM Diosynth Biotechnologiesunlistedsupplier

—GEMA Biotechunlistedsupplier

—Parexelunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

PARI Pharma GmbH

unlistedsupplier

3 more · SVRA chain ›

TRVITrevi Therapeutics, Inc.

13.99▲+0.93%· post 13.99

Mkt cap$2.0B

SVRASavara Inc

4.64▼−2.32%· post 4.66

ClosedNov 4 '26

Mkt cap$957.4M

Compare

ClosedNov 4 '26

TRVITrevi Therapeutics, Inc.

SVRASavara Inc

13.99▲+0.93%post 13.99

Price

4.64▼−2.32%post 4.66

$2.0B

Mkt cap

$957.4M

TRVI13.99▲+0.93%vsSVRA4.64▼−2.32%ClosedNov 4 '26

Price

rebased to 0%

TRVI, solidSVRA, dashed